S&P 500 (NYSE:SPY) component Merck & Co., Inc. (NYSE:MRK) will unveil its latest earnings on Friday, April 27, 2012. Merck is a global research-driven company that develops and manufactures a range of innovative pharmaceutical products to improve human and animal health.
Merck & Co., Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for net income of 97 cents per share, a rise of 5.4% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from $1.03. Between one and three months ago, the average estimate moved down. It has been unchanged at 97 cents during the last month. Analysts are projecting profit to rise by 0.8% compared to last year’s $3.80.
Past Earnings Performance: Last quarter, the company beat estimates by 2 cents, coming in at profit of 97 cents per share against an estimate of net income of. The company also topped expectations in the third quarter of the last fiscal year.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts predict a rise of 1.8% in revenue from the year-earlier quarter to $11.79 billion.
Analyst Ratings: Analysts are bullish on this stock, with 12 analysts rating it as a buy, none rating it as a sell and five rating it as a hold.
A Look Back: In the fourth quarter of the last fiscal year, the company swung to a profit of $1.51 billion (49 cents a share) from a loss of $531.7 million (16 cents) a year earlier, beating analyst estimates. Revenue rose 1.7% to $12.29 billion from $12.09 billion.
On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 1.4% in the first quarter of the last fiscal year, 7.1% in the second quarter of the last fiscal year and 8.1% in the third quarter of the last fiscal year before increasing again in the fourth quarter of the last fiscal year of the last fiscal year.
Stock Price Performance: Between February 24, 2012 and April 23, 2012, the stock price had risen 49 cents (1.3%), from $37.78 to $38.27. The stock price saw one of its best stretches over the last year between April 25, 2011 and May 4, 2011, when shares rose for eight straight days, increasing 6.5% (+$2.13) over that span. It saw one of its worst periods between July 21, 2011 and August 4, 2011 when shares fell for 11 straight days, dropping 12.9% (-$4.51) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: